Company: CGCT
Filing Date: 2025-01-29
Form Type: S-1
Source: 0001104659-25-006780
Chunk: 60

Company: Cartesian Growth Corp III
Filing Date: 2025-01-29
Form: S-1
Chunk 60
---
 results
in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares
at the time of our initial business combination. In addition, the amount of the deferred underwriting compensation payable to the underwriters
will not be adjusted for any shares that are redeemed in connection with an initial business combination. The per share amount we will
distribute to shareholders who properly exercise their redemption rights will not be reduced by the deferred underwriting compensation
and after such redemptions, the amount held in trust will continue to reflect our obligation to pay the entire deferred underwriting compensation.
The above considerations may limit our ability to complete the most desirable business combination available to us or optimize our capital
structure. As a result, our obligations to redeem public shares for which redemption is requested and to pay the deferred underwriting
commissions may not allow us to complete the most desirable business combination or optimize our capital structure.

In addition, raising additional third-party financing
may involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable levels. Furthermore, this dilution would
increase to the extent that the anti-dilution provisions of the Class B ordinary shares result in the issuance of Class A ordinary
shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares at the time of our business combination.
The above considerations may limit our ability to complete the most desirable business combination available to us or optimize our capital
structure and may result in substantial dilution from your purchase of our Class A ordinary shares. The effect of this dilution will
be greater for shareholders who do not redeem. The amount of the deferred underwriting compensation payable to the underwriters will not
be adjusted for any shares that are redeemed in connection with an initial business combination, which may further dilute your investment.
The per share amount we will distribute to shareholders who properly exercise their redemption rights will not be reduced by the deferred
underwriting compensation and after such redemptions, the per share value of shares held by non-redeeming shareholders will reflect our
obligation to pay the deferred underwriting compensation. We may not be able to generate sufficient value from the completion of our initial
business combination in order to overcome the dilutive impact of these and other factors, and, accordingly, you may incur a net loss on
your investment. Please see “— Risks Relating to Our Securities — The nominal purchase price paid by our initial shareholders for the founder shares may result in